Clinical Trials Directory

Trials / Unknown

UnknownNCT05056467

Labor Induction in Preeclampsia High-risk Women

Labor Induction Versus Expectant Management in High-risk Women for Preeclampsia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
825 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Preeclampsia (PE) is one of the leading causes of maternal and perinatal morbidity and mortality. This pregnancy-specific disorder poses to both pregnant women and their offspring an increased risk of immediate and long-term health problems. The study team is conducting a study entitled "FORECAST" (Implementation of First-trimester Screening and preventiOn of pREeClAmpSia Trial) and established the infrastructure for the first-trimester "screen and prevent" program for preterm PE. However, there is no established evidence regarding the benefit of scheduled labor induction versus expectant management among women identified as high-risk for PE with uncomplicated pregnancy at term. The investigators postulate that induction of labor at 39 weeks' gestation may possibly be an effective intervention to reduce placental complications in women with uncomplicated pregnancy by 39 weeks at high-risk PE women.

Conditions

Interventions

TypeNameDescription
PROCEDUREInduction of LaborInduction of Labor at 39 weeks of gestation

Timeline

Start date
2022-01-01
Primary completion
2024-08-30
Completion
2024-12-31
First posted
2021-09-24
Last updated
2023-05-19

Locations

8 sites across 7 countries: China, Hong Kong, Indonesia, Singapore, Taiwan, Thailand, Vietnam

Source: ClinicalTrials.gov record NCT05056467. Inclusion in this directory is not an endorsement.